Encompass Health Corp
Statements
Cash Flow
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 17.8% | 16.1% | 18.1% | 16.7% | 19.8% | 19.8% | 19.8% | 18.5% | 18.3% | 22.4% | 19.7% | 17.7% | 19.5% | |
| 5.6% | 5.6% | 5.3% | 5.6% | 5.8% | 5.6% | 5.4% | 5.5% | 5.6% | 6.2% | 5.5% | 5.7% | 5.7% | |
| 1.1% | 1.1% | 0.7% | 1.0% | 1.0% | 0.9% | 0.7% | 1.0% | 1.0% | 1.2% | 0.7% | 1.6% | 1.1% | |
| 3.7% | – | – | – | – | – | – | – | – | – | – | – | – | |
| 1.4% | -0.7% | -0.1% | -0.9% | 2.4% | 0.2% | -0.5% | -0.3% | 0.1% | 0.9% | -2.1% | 1.0% | 0.0% | |
| 12.2% | 17.9% | 10.6% | 12.1% | 10.9% | 14.1% | 11.2% | 10.8% | 12.7% | 14.8% | 10.2% | 13.8% | 12.9% | |
| -32.7% | -15.6% | -8.5% | -11.0% | -12.0% | -14.5% | -10.9% | -11.3% | -13.6% | -15.4% | -9.5% | -14.7% | -13.3% | |
| 1.2% | 1.2% | 1.2% | 1.1% | 1.1% | 1.2% | 1.2% | 1.2% | 1.2% | 1.2% | 1.3% | 1.2% | 1.2% | |
| 0.0% | 0.0% | -0.9% | -1.3% | -0.5% | -0.5% | -2.2% | -1.7% | -1.7% | -4.9% | -4.5% | -4.6% | -4.0% | |
| -2.2% | – | – | – | -10.5% | -6.2% | -1.4% | -1.5% | -1.9% | 2.7% | 5.7% | 3.5% | 2.6% | |
| -5.5% | -3.5% | -4.5% | -5.0% | -6.6% | -10.7% | -9.0% | -6.2% | -7.7% | -6.4% | -6.5% | -4.8% | -6.3% | |
| -1.1% | -3.0% | 5.2% | 0.7% | 1.2% | -5.4% | 0.0% | 1.0% | -3.0% | 0.6% | 3.8% | -1.9% | -0.1% | |
| 5.7% | -1.7% | 7.6% | 4.6% | 8.9% | 5.7% | 8.6% | 7.8% | 5.7% | 7.6% | 9.5% | 3.9% | 6.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.